RxDoctor Payments Data

Liana Proffer, MD

MOHS-Micrographic Surgery · Amarillo, TXNPI 1891770046

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.2% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Bioventus LLC at 31.7% of the total. 2025 is the largest year on record at $428, 3.7 times the $114 reported in 2019. That places this record below the midpoint for mohs-micrographic surgery clinicians in TX, where the typical reported total is $1,382.

$1,302in general payments, 2019–2025

Across 78 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bioventus LLC$412
  • Revance Therapeutics, Inc.$248
  • AbbVie$185
  • Pacira Pharmaceuticals Incorporated$119
  • Lifenet Health$89
  • Tepha Inc$62
  • plus $187 from 7 others

What the payments were for

  • Speaking & faculty fees$12810%
  • Food & beverage$1,17590%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,302 in reported general payments places this provider in the 45th percentile of 109 mohs-micrographic surgery providers in Texas.

See all mohs-micrographic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$1,147,810
Medicare patients
523
Services billed
3,313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin419$2,588
Mupirocin55$544
Clindamycin Hcl111$527
Doxycycline Hyclate14$255
Levofloxacin12$57

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Amarillo

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →